Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...

On July 30, 2024, Merck released its second quarter 2024 financial report and disclosed a significant reduction in Gardasil vaccinations, resulting in an overabundance of inventory at Merck's Chinese ...

A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...

Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") of a class action securities lawsuit.